| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.22 | 0.5 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.2 | 0.5 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.19 | 0.0001 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.16 | 0.4 |